Case for caution in expanding attention deficit hyperactivity disorder prescribing

The article argues that expanding ADHD stimulant prescribing to general practitioners in Australia, while addressing access issues, risks inadequate training and fragmented care models that prioritize volume over quality. The authors call for a national framework with mandatory education, shared care pathways, and periodic reviews to ensure holistic ADHD management rather than medication-only services.